EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia

Yongbin Chen, Scott M Johnson, Stephanie D Burr, Davide Povero, Aaron M Anderson, Cailin E McMahon, Jun Liu

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci181754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Yongbin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Triglycerides, Lipolysis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interplay between intracellular and intravascular lipolysis is crucial for maintaining circulating lipid levels and systemic energy homeostasis. Adipose triglyceride lipase (ATGL) and lipoprotein lipase (LPL), the primary triglyceride (TG) lipases responsible for these two spatially separate processes, are highly expressed in adipose tissue. Yet the mechanisms underlying their coordinated regulation remain undetermined. Here, we demonstrate that genetic ablation of G0S2, a specific inhibitory protein of ATGL, completely abolished diet-induced hypertriglyceridemia and significantly attenuated atherogenesis in mice. These effects were attributable to enhanced whole-body TG clearance, not altered hepatic TG secretion. Specifically, G0S2 deletion increased circulating LPL concentration and activity, predominantly through LPL production from white adipose tissue (WAT). Strikingly, transplantation of G0S2-deficient WAT normalized plasma TG levels in mice with hypertriglyceridemia. In conjunction with improved insulin sensitivity and decreased ANGPTL4 expression, the absence of G0S2 enhanced the stability of LPL protein in adipocytes, a phenomenon that could be reversed upon ATGL inhibition. Collectively, these findings highlight the pivotal role of adipocyte G0S2 in regulating both intracellular and intravascular lipolysis, and the possibility of targeting G0S2 as a viable pharmacological approach to reducing levels of circulating TGs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertriglyceridemiaTriglyceridesLipolysisAnimalsMiceLipoprotein LipaseMice, KnockoutLipaseAdipose Tissue, WhiteAngiopoietin-Like Protein 4MaleMice, Inbred C57BLAdipocytesDiet, High-FatAtherosclerosisAcyltransferasesCell Cycle Proteins

Stichwörter der Autor:innen

Adipose tissueAtherosclerosisEndocrinologyMetabolismObesity

Substanzen

TriglyceridesLipoprotein LipaseG0S2 protein, mouseLipasePNPLA2 protein, mouseAngptl4 protein, mouseAngiopoietin-Like Protein 4AcyltransferasesCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Division of Endocrinology, Diabetes, Metabolism, and Nutrition, and.
  • Division of Gastroenterology and Hepatology, Mayo Clinic in Rochester, Rochester, Minnesota, USA.
  • Department of Developmental Biology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Molecular Biology and Genetics Department, Cornell College of Agriculture and Life Sciences, Ithaca, New York, USA.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Chen, Y., Johnson, S. M., Burr, S. D., Povero, D., Anderson, A. M., McMahon, C. E., & Liu, J. (2025). Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia. Journal of Clinical Investigation. https://doi.org/10.1172/jci181754

Vancouver

Chen Y, Johnson SM, Burr SD, Povero D, Anderson AM, McMahon CE, et al. Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia. Journal of Clinical Investigation. 2025. doi:10.1172/jci181754

BibTeX
@article{Chen2025,
  author = {Chen, Yongbin and Johnson, Scott M and Burr, Stephanie D and Povero, Davide and Anderson, Aaron M and McMahon, Cailin E and Liu, Jun},
  title = {Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci181754}
}
Kostenlos starten →